Details for 2023187511

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR RNA-GESTEUERTEN ZIEL-DNA-MODIFIKATION UND ZUR RNA-GESTEUERTEN TRANSKRIPTIONSMODULATION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023187511

EP Publication Number

4289948

E-Number

1770643

Language

PCT Number

Publication Date

13.12.2023 A

26.02.2025 B1

Registration Date

26.02.2025

AT Publication Date

15.03.2025

Application Date

15.03.2013

Registration Number

Priorities

25.05.2012

201261652086 P

19.10.2012

201261716256 P

28.01.2013

201361757640 P

15.02.2013

201361765576 P

IPC

C12N 15/11 20060101AFI20240308BHEP

Maximum Duration of Protection

15.03.2033

Owner

The Regents of the University of California1111 Franklin Street, 12th Floor Oakland, CA 94607US

Universität WienUniversitätsring 1 1010 ViennaAT

Charpentier, EmmanuelleMax Planck Unit for the Science of Pathogens Virchowweg 12 10117 BerlinDE

Representative

Authorized Recipients

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

CHARPENTIER, Emmanuelle 10117 BerlinDE

JINEK, Martin Berkeley, 94709US

DOUDNA CATE, James Harrison Berkeley, 94705US

LIM, Wendell San Francisco, 94118US

QI, Lei Albany, 94706US

CHYLINSKI, Krzysztof 1110 ViennaAT

DOUDNA, Jennifer Berkeley, 94705US

Information about Fees